Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
about
Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathwayCoexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosisSomatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton InvolvementExpression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.Somatostatin and cancer: applying endocrinology to oncology.Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosisComparative study of somatostatin-human serum albumin fusion proteins and natural somatostatin on receptor binding, internalization and activation.Mechanism and its regulation of tumor-induced angiogenesis.Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.SST3-selective potent peptidic somatostatin receptor antagonists.Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumoursPeptide receptor targeting in cancer: the somatostatin paradigm.The potential role of somatostatin analogues in breast cancer treatment.Future treatment strategies of aggressive pituitary tumors.Global changes in STAT target selection and transcription regulation upon interferon treatmentsSomatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells.Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.Antineoplastic effects of octreotide on human gallbladder cancer cells in vitro.Somatostatin receptor 1-5; expression profiles during rat development.Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signaling.Doxorubicin and octreotide induce a 40 kDa breakdown product of p53 in human hepatoma and tumoral colon cell lines.The Concept of Divergent Targeting through the Activation and Inhibition of Receptors as a Novel Chemotherapeutic Strategy: Signaling Responses to Strong DNA-Reactive Combinatorial Mimicries.Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells.Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors.Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Q24300160-4E48A24F-DB55-4886-A948-34B9C8AA78A8Q24337066-8C3A6194-B621-4261-AF03-D542EA5E9806Q24681476-D9876D94-AE40-4FF7-B6E1-6FF311975338Q26770701-A2C9FF1A-7A95-4805-9DFA-F167C58888B0Q30487782-0F91FE04-DED6-4658-91B8-E284DB93CFE8Q34181921-36C08DB2-459D-4A8C-8009-B81401B736E0Q34466979-3C3EC489-44CA-4943-98C1-42F97DB1FA82Q35108395-7E943BB9-149F-442A-81FE-1F35CA875F29Q35151099-644B6DFF-A930-4B37-8429-59EB629483FDQ35216414-0A3B46CF-4048-4422-AC45-BCF1F24CDF6DQ35582980-5D859B97-CF88-4B55-BCD0-A9534141C248Q35621231-C1F84DFE-F44C-4827-91A0-5B3EFE447E9AQ36624229-B53AA010-1E0C-4961-8C44-7AF660D85F0CQ36638046-3AB7810B-5623-4AA8-8063-1917CBD74309Q36988009-819FE0F1-9093-4895-8A6E-45E9F1DB90C6Q37266737-A3AABC4C-587F-46C4-B63F-1C69174D1BCDQ38318251-C7633C39-E96B-46E3-9CB1-235640592FCEQ39842258-58EF6334-82B1-4F2C-B0EA-CE86F0E25CB4Q40537154-06A91408-95E7-4C72-975D-1E82C269B409Q40571857-F64FFC8A-8B0D-4280-B54E-7B913B11BF68Q40995512-CEB963B8-7612-489C-A180-19FB42D0DE02Q41568422-947FF423-8551-482C-8589-CB08D28795C4Q42134676-8754501F-57A9-41CA-AB7D-EA7011AB5C08Q42560434-B6494AFE-0B80-4367-9779-84B93BC03AA8Q42573914-A51CB224-7E05-4D20-8E59-378D7AB93A4EQ42744657-55E9FD22-B1EB-41C2-BA37-9C44CD69A4B7Q43006483-5BA05742-91E4-4ED5-A513-FE9510426077Q57144951-971502BF-FEED-41E7-A790-CFD873B35BAC
P2860
Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Subtype-selective induction of ...... human somatostatin receptor 3
@ast
Subtype-selective induction of ...... human somatostatin receptor 3
@en
Subtype-selective induction of ...... human somatostatin receptor 3
@en-gb
Subtype-selective induction of ...... human somatostatin receptor 3
@nl
type
label
Subtype-selective induction of ...... human somatostatin receptor 3
@ast
Subtype-selective induction of ...... human somatostatin receptor 3
@en
Subtype-selective induction of ...... human somatostatin receptor 3
@en-gb
Subtype-selective induction of ...... human somatostatin receptor 3
@nl
prefLabel
Subtype-selective induction of ...... human somatostatin receptor 3
@ast
Subtype-selective induction of ...... human somatostatin receptor 3
@en
Subtype-selective induction of ...... human somatostatin receptor 3
@en-gb
Subtype-selective induction of ...... human somatostatin receptor 3
@nl
P2093
P921
P1476
Subtype-selective induction of ...... human somatostatin receptor 3
@en
P2093
P304
P356
10.1210/MEND.10.12.8961277
P407
P577
1996-12-01T00:00:00Z